Gene testing firm 23andMe said on Sunday it had filed for Chapter 11 bankruptcy protection in order to facilitate its sale, after years of struggling to find a sustainable business model.In a statement announcing the bankruptcy, the firm said its CEO, Anne Wojcicki, had resigned effective immediately. She will remain on the company맥스카지노�s board of directors.맥스카지노�After a thorough evaluation of strategic alternatives, we have determined that a court-supervised sale process is the best path forward to maximize the value of the business,맥스카지노� Mark Jensen, chair and member of the Special Committee of the board of directors, said in the statement.Late last year, the company said it was cutting about 40% of its workforce - around 200 employees - and discontinuing further development of all its therapies as part of a restructuring program, according to Reuters.In September, all seven of the company맥스카지노�s independent directors resigned en masse, citing their frustration with the CEO맥스카지노�s 맥스카지노�strategic direction맥스카지노� and efforts to take 23andMe private.The company, which went public in 2021, had never made a profit. The stock shot up following the listing, briefly valuing the company at $6 billion. Wojcicki, who owned 49% of the company, became a billionaire.Its core product, an at-home DNA testing kit, offers 맥스카지노�personalized genetic insights맥스카지노� that the company says can flag potential health risks such as one맥스카지노�s likelihood of developing Alzheimers or certain cancers.23andMe tried to convert one-time buyers into subscribers with the promise of continued feedback and personalized wellness plans but had reportedly fallen short of its goals.